Tag: NASDAQ:LJPC

Finance

Market Wrap Up: Chevron Corporation (NYSE:CVX), Semtech Corporation (NASDAQ:SMTC), Craft Brew Alliance, Inc. (NASDAQ:BREW), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), JPMorgan Chase (NYSE:JPM)

New Zealand awarded 15 oil and gas exploration licenses on Tuesday, with U.S. giant Chevron Corporation (NYSE:CVX) and India’s ONGC Videsh joining the hunt in the South Pacific country for the first time. Chevron is partnering with Norway’s Statoil to explore three prospects off the lightly explored south-east coast of the North Island. Chevron Corporation (NYSE:CVX) belongs to Basic Materials sector. Its net profit margin … Continue reading Market Wrap Up: Chevron Corporation (NYSE:CVX), Semtech Corporation (NASDAQ:SMTC), Craft Brew Alliance, Inc. (NASDAQ:BREW), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), JPMorgan Chase (NYSE:JPM)

Jayne Crisman
Finance

Stock Highlights: Gerdau (NYSE:GGB), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), TriNet Group, Inc. (NYSE:TNET), Harley-Davidson, Inc. (NYSE:HOG), Credit Acceptance Corp. (NASDAQ:CACC)

Gerdau SA (NYSE:GGB) has earned credit rating from Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Gerdau S.A. (NYSE:GGB) belongs to Basic Materials sector. Its net profit margin is 4.20% and weekly performance is -11.07%. On last trading day … Continue reading Stock Highlights: Gerdau (NYSE:GGB), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), TriNet Group, Inc. (NYSE:TNET), Harley-Davidson, Inc. (NYSE:HOG), Credit Acceptance Corp. (NASDAQ:CACC)

John Meady
Finance

Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

In June, Esperion Therapeutics Inc. (NASDAQ:ESPR), an Ann Arbor-based early-stage pharmaceutical company, raised $73 million in its IPO. It plans a secondary offering this year, based on trial results of its cholesterol-lowering drug. Esperion Therapeutics Inc (NASDAQ:ESPR) stock performance was -5.04% in last session and finished the day at $14.69. Traded volume was 31,400 shares in the last session and the average volume of the … Continue reading Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

John Bellich
Finance

Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the “Company” or “La Jolla”) a leader in the development of therapeutics targeting significant unmet life-threatening diseases today announced that George Tidmarsh M.D. Ph.D. President and Chief Executive Officer will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its … Continue reading Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

Jayne Crisman